|
JP2020005642A
|
|
Pharmaceutical for preventing or treating hypertension
|
|
JP2020201742A
|
|
Monitoring device and method
|
|
JP2020199072A
|
|
Cerebral apoplexy determination device, method, and program
|
|
JP2020186297A
|
|
Modified polyethyleneimine and method for producing the same
|
|
JP2020162447A
|
|
Container for cell concentration
|
|
JP2020116274A
|
|
Recording device, recording method, and program
|
|
JP2020051749A
|
|
Auxiliary diagnostic method for mci and dementia using blood samples
|
|
JP2020027569A
|
|
Biological sound diagnostic device
|
|
JP2020011931A
|
|
Antibody for detecting human peripheral cholinergic nerve
|
|
JP2019216666A
|
|
Premature aging model animal
|
|
JP2019205552A
|
|
Cell collection material having recovery function of hypo-immune state and cell collection column
|
|
JP2019187966A
|
|
Diagnosis support device, machine learning device, diagnosis support method, machine learning method, and machine learning program
|
|
JP2018117638A
|
|
Methods for screening compounds for treating and/or preventing diseases associated with tdp-43 agglomerate accumulation
|
|
JP2019182759A
|
|
Negative contrast medium for x-rays
|
|
JP2019152564A
|
|
Holder for immunostaining
|
|
JP2019115561A
|
|
Psychological state determination method, determination device, determination system, and determination program
|
|
JP2019013517A
|
|
Composition for air leak detection in lung surgery
|
|
JP2018194622A
|
|
Cord blood collection model tool
|
|
JP2018169349A
|
|
Method for measuring amyloid beta protein and tau protein and/or phosphorylated tau protein
|
|
JP2018104307A
|
|
Pharmaceutical composition
|
